Justin S Cisar

USPTO Granted Patents = 22 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 6.2

ph-index = 7

Forward Citations = 145(Granted Patents)

Company Filing History:

12 out of 18

Abide Therapeutics, Inc.

patents

8 out of 1,186

The Scripps Research Institute

patents

5 out of 12

Lundbeck La Jolla Research Center, Inc.

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

22 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12378219 - Crystalline forms of a MAGL inhibitor (2025-08-05),

2. 12318383 - Dual MAGL and FAAH inhibitors (2025-06-03),

3. 12018004 - Carbamate compounds and methods of making and using same (2024-06-25),

4. 11530189 - Carbamate compounds and methods of making and using same (2022-12-20),

5. 11434222 - MAGL inhibitors (2022-09-06),

6. 11149037 - Pyrazole MAGL inhibitors (2021-10-19),

7. 11129827 - Dual MAGL and FAAH inhibitors (2021-09-28),

8. 11021453 - Carbamate compounds and methods of making and using same (2021-06-01),

9. 10781211 - Spirocycle compounds and methods of making and using same (2020-09-22),

10. 10463753 - Radiolabeled monoacylglycerol lipase occupancy probe (2019-11-05),

11. 10385057 - Pyrazole compounds and methods of making and using same (2019-08-20),

12. 10350205 - Dual MAGL and FAAH inhibitors (2019-07-16),

13. 10323038 - Pyrazole compounds and methods of making and using same (2019-06-18),

14. 10093630 - Pyrazole compounds and methods of making and using same (2018-10-09),

15. 10030020 - Spirocycle compounds and methods of making and using same (2018-07-24),

Title: Innovative Contributions of Justin S. Cisar in Medicinal Chemistry

Introduction: Justin S. Cisar is a prominent inventor based in San Diego, California, known for his significant contributions to the field of medicinal chemistry. With an impressive portfolio of 20 patents, Cisar's work is characterized by the development of novel compounds aimed at addressing critical medical conditions.

Latest Patents: Among his latest patents, Cisar has focused on "Carbamate Compounds and Methods of Making and Using Same." This disclosure details compounds and compositions that may serve as modulators of MAGL and/or ABHD6, highlighting their potential use as medicinal agents. The patent also outlines processes for preparing these compounds and pharmaceutical compositions that include them as active agents. Furthermore, it describes methods for treating patients with post-traumatic stress disorder by administering the disclosed compounds or compositions.

Career Highlights: Cisar has made notable advancements in his field through his work at reputable organizations. He has been associated with Abide Therapeutics, Inc. and The Scripps Research Institute, where he contributed to innovative research and product development.

Collaborations: Throughout his career, Justin S. Cisar has collaborated with talented professionals, including Cheryl A. Grice and Todd Kevin Jones. These partnerships have helped foster an environment of creativity and innovation within the organizations he has worked with.

Conclusion: Justin S. Cisar's inventive spirit and dedication to the medicinal chemistry field have led to significant advancements in therapeutic treatments. His patents not only reflect his expertise but also offer hope for patients dealing with challenging medical conditions.

This text is generated by artificial intelligence and may not be accurate.